rs10495970
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs10495970(A;A) |
Make rs10495970(A;G) |
Make rs10495970(G;G) |
Reference | GRCh38 38.1/142 |
Chromosome | 2 |
Position | 49264671 |
is a | snp |
is | mentioned by |
dbSNP | rs10495970 |
dbSNP (classic) | rs10495970 |
ClinGen | rs10495970 |
ebi | rs10495970 |
HLI | rs10495970 |
Exac | rs10495970 |
Gnomad | rs10495970 |
Varsome | rs10495970 |
LitVar | rs10495970 |
Map | rs10495970 |
PheGenI | rs10495970 |
Biobank | rs10495970 |
1000 genomes | rs10495970 |
hgdp | rs10495970 |
ensembl | rs10495970 |
geneview | rs10495970 |
scholar | rs10495970 |
rs10495970 | |
pharmgkb | rs10495970 |
gwascentral | rs10495970 |
openSNP | rs10495970 |
23andMe | rs10495970 |
SNPshot | rs10495970 |
SNPdbe | rs10495970 |
MSV3d | rs10495970 |
GWAS Ctlg | rs10495970 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 24554482] |
Trait | Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) |
Title | Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384. |
Risk Allele | |
P-val | 5E-7 |
Odds Ratio | 10.30 [NR] |